Neil Dunavin

484 total citations
26 papers, 285 citations indexed

About

Neil Dunavin is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Neil Dunavin has authored 26 papers receiving a total of 285 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 13 papers in Hematology and 9 papers in Molecular Biology. Recurrent topics in Neil Dunavin's work include Hematopoietic Stem Cell Transplantation (8 papers), CAR-T cell therapy research (6 papers) and Immune Cell Function and Interaction (5 papers). Neil Dunavin is often cited by papers focused on Hematopoietic Stem Cell Transplantation (8 papers), CAR-T cell therapy research (6 papers) and Immune Cell Function and Interaction (5 papers). Neil Dunavin collaborates with scholars based in United States, United Kingdom and China. Neil Dunavin's co-authors include Meizhang Li, Joseph P. McGuirk, Ajoy Dias, Andrew K. Godwin, Siddhartha Ganguly, Haitham Abdelhakim, Sunil Abhyankar, Rupal P. Soder, Buddhadeb Dawn and Harsh B. Pathak and has published in prestigious journals such as Blood, Scientific Reports and British Journal of Haematology.

In The Last Decade

Neil Dunavin

25 papers receiving 280 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Neil Dunavin United States 7 151 114 89 74 56 26 285
Cristina Robledo Spain 13 132 0.9× 174 1.5× 81 0.9× 163 2.2× 42 0.8× 27 399
Yuye Shi China 12 129 0.9× 130 1.1× 54 0.6× 89 1.2× 40 0.7× 38 340
Sabrin Tahri Netherlands 9 187 1.2× 246 2.2× 138 1.6× 62 0.8× 100 1.8× 25 401
Julie C. Porcher United States 8 106 0.7× 65 0.6× 126 1.4× 71 1.0× 69 1.2× 13 399
Clotaire Danho France 4 97 0.6× 229 2.0× 128 1.4× 134 1.8× 41 0.7× 4 331
Paulina M. H. van Strien Netherlands 7 194 1.3× 137 1.2× 46 0.5× 135 1.8× 94 1.7× 11 400
Shen Y. Heazlewood Australia 11 75 0.5× 204 1.8× 46 0.5× 84 1.1× 98 1.8× 12 321
Jean‐François Geay France 6 80 0.5× 123 1.1× 112 1.3× 46 0.6× 114 2.0× 9 276
Mark D. Ewalt United States 12 132 0.9× 137 1.2× 47 0.5× 124 1.7× 52 0.9× 31 340
Antoine Crinquette France 3 156 1.0× 200 1.8× 111 1.2× 87 1.2× 38 0.7× 4 352

Countries citing papers authored by Neil Dunavin

Since Specialization
Citations

This map shows the geographic impact of Neil Dunavin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil Dunavin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil Dunavin more than expected).

Fields of papers citing papers by Neil Dunavin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neil Dunavin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil Dunavin. The network helps show where Neil Dunavin may publish in the future.

Co-authorship network of co-authors of Neil Dunavin

This figure shows the co-authorship network connecting the top 25 collaborators of Neil Dunavin. A scholar is included among the top collaborators of Neil Dunavin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neil Dunavin. Neil Dunavin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
DiNardo, Courtney D., Daniel A. Pollyea, Ahmed Aribi, et al.. (2023). P536: A FIRST-IN-HUMAN PHASE 1 STUDY OF IO-202 (ANTI-LILRB4 MAB) IN ACUTE MYELOID LEUKEMIA (AML) WITH MONOCYTIC DIFFERENTIATION AND CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) PATIENTS. HemaSphere. 7(S3). e605335a–e605335a. 5 indexed citations
2.
Dunavin, Neil, Lih-Wen Mau, Clint Divine, et al.. (2020). Health Care Reimbursement, Service Utilization, and Outcomes among Medicare Beneficiaries with Multiple Myeloma Receiving Autologous Hematopoietic Cell Transplantation in Inpatient and Outpatient Settings. Biology of Blood and Marrow Transplantation. 26(4). 805–813. 5 indexed citations
3.
Soder, Rupal P., Buddhadeb Dawn, Mark L. Weiss, et al.. (2020). A Phase I Study to Evaluate Two Doses of Wharton’s Jelly-Derived Mesenchymal Stromal Cells for the Treatment of De Novo High-Risk or Steroid-Refractory Acute Graft Versus Host Disease. Stem Cell Reviews and Reports. 16(5). 979–991. 29 indexed citations
4.
Abdelhakim, Haitham, Meizhang Li, Stephen Hyter, et al.. (2020). Adherent cell depletion promotes the expansion of renal cell carcinoma infiltrating T cells with optimal characteristics for adoptive transfer. Journal for ImmunoTherapy of Cancer. 8(2). e000706–e000706. 5 indexed citations
5.
Kumar, Amar, Dharmalingam Subramaniam, Neil Dunavin, et al.. (2019). Functional cooperativity of p97 and histone deacetylase 6 in mediating DNA repair in mantle cell lymphoma cells. Leukemia. 33(7). 1675–1686. 13 indexed citations
6.
Abdelhakim, Haitham, et al.. (2019). The Activation Marker CD137 (4-1BB) Identifies a Highly Active Subset of Donor Lymphocytes Against Acute Myeloid Leukemia. Biology of Blood and Marrow Transplantation. 25(3). S297–S298. 1 indexed citations
7.
Gao, Bo, Zongmin Jiang, Zhongshan Yang, et al.. (2018). Upregulation of chemokine CXCL10 enhances chronic pulmonary inflammation in tree shrew collagen-induced arthritis. Scientific Reports. 8(1). 9993–9993. 24 indexed citations
8.
Dunavin, Neil, Meizhang Li, Safinur Atay, et al.. (2018). CRISPR/Cas9-Mediated Disruption of PD-L1 Reduces the T Cell Suppressive Effect of Wharton's Jelly Mesenchymal Stromal Cells and Their Extracellular Vesicles. Blood. 132(Supplement 1). 5095–5095. 2 indexed citations
10.
Abdelhakim, Haitham, Neil Dunavin, Meizhang Li, et al.. (2018). LAG3 Promotes Acute Myeloid Leukemia-Induced Immune Suppression. Blood. 132(Supplement 1). 2414–2414. 1 indexed citations
12.
Bosak, Kelly, Tara L. Lin, Neil Dunavin, et al.. (2018). Using Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) Tool to Explore Quality of Life in Patients Undergoing Autologous Stem Cell Transplantation in the Outpatient Setting. Biology of Blood and Marrow Transplantation. 24(3). S262–S263. 1 indexed citations
13.
Mohyuddin, Ghulam Rehman, Leyla Shune, Tara L. Lin, et al.. (2017). Utility of routine surveillance imaging for diffuse large B-cell lymphoma post autologous transplant. Hematology/Oncology and Stem Cell Therapy. 11(3). 135–141. 1 indexed citations
14.
Dunavin, Neil, Jeanine Superata, Quan Yu, et al.. (2017). Cellular immune profiling after sequential clofarabine and lenalidomide for high risk myelodysplastic syndromes and acute myeloid leukemia. Leukemia Research Reports. 7. 40–44. 4 indexed citations
15.
Dunavin, Neil, Ajoy Dias, Meizhang Li, & Joseph P. McGuirk. (2017). Mesenchymal Stromal Cells: What Is the Mechanism in Acute Graft-Versus-Host Disease?. Biomedicines. 5(3). 39–39. 37 indexed citations
16.
Tian, Xin, Neil Dunavin, Nancy F. Hensel, et al.. (2016). Improved reproducibility and quality of GvHD biomarker assay: application of multiplex microfluidic channel system. Bone Marrow Transplantation. 51(12). 1615–1616.
17.
Dunavin, Neil, Christopher S. Hourigan, Robert Q. Le, et al.. (2015). CD34+ selection and the severity of oropharyngeal mucositis in total body irradiation-based allogeneic stem cell transplantation. Supportive Care in Cancer. 24(2). 815–822. 5 indexed citations
18.
Bond, David A., Neil Dunavin, & Gregory A. Otterson. (2015). Mutational Profiling of Second Primary Lung Cancers in Patients Who Have Received Radiation for the Treatment of Hodgkin's Disease. Cancer Investigation. 33(3). 86–88. 2 indexed citations
19.
Le, Robert Q., Xin Tian, Sawa Ito, et al.. (2014). Clinical Comorbidity Measures and Predictive Scores in Ex Vivo T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation. Blood. 124(21). 2550–2550. 1 indexed citations
20.
Dunavin, Neil, Lai Wei, Patrick Elder, et al.. (2012). Early versus delayed autologous stem cell transplant in patients receiving novel therapies for multiple myeloma. Leukemia & lymphoma. 54(8). 1658–1664. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026